Millennium Biotechnologies Group, Inc. Signs a Letter of Intent With an International Pharmaceutical Company for the Distribution of Resurgex Line in the Canadian Oncology Market

TORONTO, March 27, 2007 (PRIME NEWSWIRE) (PRIMEZONE) -- Millennium Biotechnologies Group, Inc. (OTCBB:MBTG) announces today that it signed a letter of intent with a Canadian subsidiary of an international pharmaceutical company on terms for the distribution and marketing of its Resurgex product line for the Canadian oncology market.